Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 4

Results For "Biomanufacturing"

41 News Found

GenScript wins Best CDMO award for the third time
News | March 30, 2022

GenScript wins Best CDMO award for the third time

The award also follows GenScript's recognition at the Korea Bioprocessing Excellence Awards in 2021 for the "Best Contract Development and Manufacturing Organization Award".


IDT Biologika collaborates with Exothera to push forward the scale-up of viral vaccines
Biotech | March 01, 2022

IDT Biologika collaborates with Exothera to push forward the scale-up of viral vaccines

This innovative biomanufacturing technology will help to deliver cost-effective viral production that is unmatched in the industry


Canada approves plant-based Covid-19 vaccine
News | February 25, 2022

Canada approves plant-based Covid-19 vaccine

Medicago and GSK collaborated on Covifenz, an adjuvanted plant-based vaccine


Prestige BioPharma’s facility receives EU-GMP certification
Biotech | February 22, 2022

Prestige BioPharma’s facility receives EU-GMP certification

The facility will manufacture its Herceptin biosimilar, Tuznue


Germfree launches novel mobile cleanroom technology for advanced therapies
Biotech | February 04, 2022

Germfree launches novel mobile cleanroom technology for advanced therapies

Fast, flexible space allows clinical trials to start when needed. A trial can become operational, pivot or scale without traditional capital building expenditures


Samsung Biologics expands tie-up with AstraZeneca to include cancer therapy
Biotech | December 14, 2021

Samsung Biologics expands tie-up with AstraZeneca to include cancer therapy

The company will manufacture a cancer immunotherapy product from 2022


GreenLight Biosciences and Samsung Biologics to build vaccine capacity
Biotech | November 25, 2021

GreenLight Biosciences and Samsung Biologics to build vaccine capacity

The partnership will help advance GreenLight's messenger RNA Covid-19 vaccine candidate


Resilience and Harvard announce five-year R&D alliance
News | October 18, 2021

Resilience and Harvard announce five-year R&D alliance

First anticipated spinout from the alliance, Circle Therapeutics, to develop novel muscle stem cell therapies for a variety of skeletal muscle disorders


DCGI approves Enzene biosimilar Denosumab for Osteoporosis
Drug Approval | August 28, 2021

DCGI approves Enzene biosimilar Denosumab for Osteoporosis

This is Enzene Biosciences third biosimilar to be approved